首页> 外文会议>Society for Biomaterials annual meeting and exposition >Surface fluorination of polylactides for enhanced hemocompatibility
【24h】

Surface fluorination of polylactides for enhanced hemocompatibility

机译:聚乳酸表面氟化可增强血液相容性

获取原文
获取外文期刊封面目录资料

摘要

We have established a novel approach for functionalizing PLA with trifluoromethyl groups to improve its hemocompatibility. TFICP immobilized surfaces had higher hydrophobicity and showed no sign of cytotoxicity toward NIH-3T3 fibroblast cells. So far, we have seen differentiated protein adsorption behavior of fluorinated PLA compared to control samples. TFICP immobilized surfaces adsorbed higher amount of the Alb in human blood plasma solutions. In addition, we observed greater amount of retained Alb on these surfaces after incubating them with 2% SDS. We therefore would expect these fluorinated surfaces to show improved blood compatibility in vivo as tight binding of Alb contributes to improved blood compatibility by passivating the surfaces of these polymers. Since a preadsorbed layer of Alb inhibits subsequent adhesion of Fg and decreases platelet adhesion producing a potentially less thrombogenic surfaces (5). In fact, fluorinated surfaces have shown satisfactory clinical performance and have often been the material of choice for blood contact applications. Interaction of platelets with these fluorinated surfaces are currently under investigation.
机译:我们已经建立了一种新的方法来用三氟甲基官能化PLA,以改善其血液相容性。固定化TFICP的表面具有较高的疏水性,并且对NIH-3T3成纤维细胞没有细胞毒性的迹象。到目前为止,我们已经看到与对照样品相比,氟化PLA的蛋白质吸附行为有所不同。 TFICP固定化的表面在人血浆溶液中吸附了更多量的Alb。此外,在将它们与2%SDS孵育后,我们观察到这些表面上残留的Alb量更大。因此,我们希望这些氟化的表面在体内显示出改善的血液相容性,因为Alb的紧密结合通过钝化这些聚合物的表面有助于改善血液的相容性。由于预先吸附的Alb层抑制了Fg的后续粘附并降低了血小板粘附,从而产生了可能更少的血栓形成表面(5)。实际上,氟化表面已显示出令人满意的临床性能,并经常成为血液接触应用的选择材料。目前正在研究血小板与这些氟化表面的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号